Chest CT and Lung Imaging

A standard diagnostic chest CT is ordered to evaluate a specific symptom, an abnormal chest X-ray finding, or a known lung problem, and uses a radiation dose and image protocol chosen to answer that particular clinical question, sometimes with intravenous contrast. Low-dose CT (LDCT) is a distinct test used specifically for annual lung cancer screening in eligible adults without symptoms. It uses a substantially reduced radiation dose calibrated for that screening purpose and is not typically used to work up a symptom or a known abnormality in detail.

HRCT uses thin image slices and a reconstruction technique optimized to show fine detail within the lung tissue itself, rather than the thicker slices used on a standard diagnostic chest CT. This makes HRCT the preferred imaging test when interstitial lung disease is suspected, since it can show subtle patterns of scarring or inflammation that a standard chest CT protocol might not resolve as clearly.

It depends on why the scan is being done. Non-contrast chest CT is generally used for HRCT evaluation of lung tissue and for low-dose CT lung cancer screening, since contrast is not needed to see the lung parenchyma itself or small nodules. Intravenous contrast is often added to a standard diagnostic chest CT when the question involves blood vessels, lymph nodes, or certain masses, for example when evaluating for a blood clot in the lungs or characterizing a mass more fully. Your physician or the radiology team will determine whether contrast is appropriate for your specific reason for testing.

Radiation dose varies meaningfully by scan type. Low-dose CT for lung cancer screening uses a substantially reduced dose specifically calibrated for that screening purpose, while a standard diagnostic chest CT uses a higher dose appropriate to fully characterizing a known or suspected problem. Both are considered acceptable and medically justified for their intended use, and modern CT technology has continued to reduce dose while maintaining image quality. If you have specific concerns about cumulative radiation exposure, for example from having had multiple prior scans, it is reasonable to raise that directly with your ordering physician.

A chest CT is generally quick and painless. You lie on a table that moves through a large, open, ring-shaped scanner while you hold your breath briefly for each set of images. No sedation is needed. If contrast is used, it is typically given through an intravenous line in your arm, and you may notice a brief warm sensation as it is injected. Most chest CT appointments, including check-in and any contrast preparation, take well under an hour, and the scan itself typically takes only a few minutes.

Non-contrast chest CT, including HRCT and low-dose CT screening, generally requires no special preparation. If intravenous contrast is planned, you may be asked to avoid food for a few hours beforehand and to inform the imaging team about kidney problems, prior contrast reactions, or allergies, since these can affect whether and how contrast is used. Specific instructions will come from the imaging facility scheduling your scan.

Lung-RADS is a standardized reporting system used for low-dose CT lung cancer screening exams. It sorts findings into categories, ranging from a negative or benign-appearing scan that simply continues on the normal annual screening schedule, to findings that warrant a shorter-interval follow-up CT, to findings suspicious enough to prompt additional imaging or further evaluation. The category assigned helps standardize how quickly and how closely a finding needs to be followed. Lung-RADS applies specifically to screening CTs; standard diagnostic chest CTs and HRCT scans are reported in narrative form rather than with a Lung-RADS category.

No. Small lung nodules are a common finding on chest CT, particularly low-dose screening CT, and the great majority are not cancer. Many represent old, healed infection or other benign processes. What happens next depends on the nodule's size and appearance together with your personal risk factors, and is covered in more detail on the pulmonary nodules and pulmonary nodule follow-up pages.

HRCT is a central part of diagnosing interstitial lung disease and, in some presentations, can show a pattern specific enough to support a diagnosis without a lung biopsy. In other cases, HRCT findings are combined with your history, exposure review, pulmonary function testing, and sometimes a multidisciplinary discussion among specialists to reach a diagnosis. HRCT is best understood as a key piece of the diagnostic evaluation rather than a stand-alone answer in every case.